It has been shown that migratory Th cells from patients with MS express cytokines that target CNS homing molecules, thereby potentially fostering the proliferation of pathogenic CD4+ effector memory T cells within the inflamed CNS. The gene discussed is CD4; the disease is myeloid sarcoma.